Frank, Rimerman Advisors LLC Bristol Myers Squibb CO Transaction History
Frank, Rimerman Advisors LLC
- $1.36 Billion
- Q4 2024
A detailed history of Frank, Rimerman Advisors LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Frank, Rimerman Advisors LLC holds 41,378 shares of BMY stock, worth $2.25 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
41,378
Previous 39,711
4.2%
Holding current value
$2.25 Million
Previous $2.06 Million
13.87%
% of portfolio
0.17%
Previous 0.15%
Shares
4 transactions
Others Institutions Holding BMY
# of Institutions
2,745Shares Held
1.57BCall Options Held
27.9MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$10.3 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.64 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.23 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.18 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.28 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $116B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...